OPA1 and myopathy: The anti-atrophic effect of OPA1 overexpression was not confined to acute muscle loss caused by denervation, but also counteracted chronic muscle loss and myopathy caused by a genetic mitochondrial defect (Civiletto et al., 2015 [this issue of Cell Metabolism]), further substantiating the key role of OPA1 in the control of muscle atrophy.